Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITLECITINIB vs RITONAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITLECITINIB vs RITONAVIR: Safety Overview

Metric RITLECITINIB RITONAVIR
Total FAERS Reports 1,441 11,980
Deaths Reported 1 1,190
Death Rate 0.1% 9.9%
Hospitalizations 47 2,925
Average Patient Age 34.7 yrs 43.8 yrs
% Female Patients 65.0% 43.8%
FDA Approval Date Jun 23, 2023 Dec 3, 2020
Manufacturer U.S. Pharmaceuticals AbbVie Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued